Breast Carcinoma In Situ
NCI Definition: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.) 
There are 2 clinical trials for breast carcinoma in situ, of which 2 are open and 0 are completed or closed. Of the trials that contain breast carcinoma in situ as an inclusion criterion, 1 is early phase 1 (1 open) and 1 is phase 2 (1 open).
Atorvastatin, high-dose rate brachytherapy, and metformin are the most common interventions in breast carcinoma in situ clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.